The outcome of re-treatment of relapsed hepatitis C virus infection in a resource-limited setting
Naguib, Gina Gamal; Michael, Tari George; Elshazly, Yehia; Wahdan, Maha Magdy; Aya Mostafa; Ahmed, Ossama Ashraf; Dabbous, Hany; Aly, Heba Ismail Saad; Shaker, Mohamed Kamal; Elbaz, Hosam Samir; El-Serafy, Magdy; Doss, Wahid; Abd-Elsalam, Sherief; El-Sayed, Manal Hamdy;
Abstract
The aim of this study was to compare efficacy and safety of different combination regimens in re-treatment of HCV in the setting of inaccessibility of resistance testing. This real-life prospective study included 86 chronic HCV infected patients who experienced failure of treatment treated at Faculty of Medicine Ain shams Research Institute (MASRI) since 2018. 64% of the patients were males, with median age 50.2 years. They were re-treated using 1 of 3 proposed regimens of DAA combinations. One group received PAR/OMB/SOF/RBV for 12 weeks, another group received SOF/DAC/SIM/RBV for 12 weeks and a third received SOF/DAC/RBV for 24 weeks. Response to different regimens was assessed by comparing sustained virologic response (SVR) of each. Monitoring the occurrence of adverse events was performed. SVR was achieved in all but 3 patients (96.5% SVR), one in the SOF/DAC/SIM/RBV group and two in the SOF/DAC/RBV group. The group receiving RBV had more anaemia and hyperbilirubinemia. The first treatment regimen used was a significant predictor to SVR achievement. This study presents alternative treatment regimens for re-treatment of HCV patients in areas with limited resources in the case of non-availability of other regimens as velpatasvir, voxilaprevir, grazoprevir, elbasvir.
Other data
Title | The outcome of re-treatment of relapsed hepatitis C virus infection in a resource-limited setting | Authors | Naguib, Gina Gamal; Michael, Tari George; Elshazly, Yehia; Wahdan, Maha Magdy; Aya Mostafa ; Ahmed, Ossama Ashraf; Dabbous, Hany; Aly, Heba Ismail Saad; Shaker, Mohamed Kamal; Elbaz, Hosam Samir; El-Serafy, Magdy; Doss, Wahid; Abd-Elsalam, Sherief; El-Sayed, Manal Hamdy | Keywords | Cirrhosis;HCV;Relapsers;Resistance;Sofosbuvir;Viral hepatitis | Issue Date | Sep-2021 | Journal | Virusdisease | Volume | 32 | Start page | 582 | End page | 588 | ISSN | 2347-3584 | DOI | 10.1007/s13337-021-00712-4 | PubMed ID | 34631983 | Scopus ID | 2-s2.0-85111274057 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.